Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]US Exclusivities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Bexagliflozin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bexagliflozin, including repackagers and relabelers. The FDA regulates Bexagliflozin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bexagliflozin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bexagliflozin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bexagliflozin supplier is an individual or a company that provides Bexagliflozin active pharmaceutical ingredient (API) or Bexagliflozin finished formulations upon request. The Bexagliflozin suppliers may include Bexagliflozin API manufacturers, exporters, distributors and traders.
click here to find a list of Bexagliflozin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bexagliflozin DMF (Drug Master File) is a document detailing the whole manufacturing process of Bexagliflozin active pharmaceutical ingredient (API) in detail. Different forms of Bexagliflozin DMFs exist exist since differing nations have different regulations, such as Bexagliflozin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bexagliflozin DMF submitted to regulatory agencies in the US is known as a USDMF. Bexagliflozin USDMF includes data on Bexagliflozin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bexagliflozin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bexagliflozin suppliers with USDMF on PharmaCompass.
A Bexagliflozin written confirmation (Bexagliflozin WC) is an official document issued by a regulatory agency to a Bexagliflozin manufacturer, verifying that the manufacturing facility of a Bexagliflozin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bexagliflozin APIs or Bexagliflozin finished pharmaceutical products to another nation, regulatory agencies frequently require a Bexagliflozin WC (written confirmation) as part of the regulatory process.
click here to find a list of Bexagliflozin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bexagliflozin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bexagliflozin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bexagliflozin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bexagliflozin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bexagliflozin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bexagliflozin suppliers with NDC on PharmaCompass.
Bexagliflozin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bexagliflozin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bexagliflozin GMP manufacturer or Bexagliflozin GMP API supplier for your needs.
A Bexagliflozin CoA (Certificate of Analysis) is a formal document that attests to Bexagliflozin's compliance with Bexagliflozin specifications and serves as a tool for batch-level quality control.
Bexagliflozin CoA mostly includes findings from lab analyses of a specific batch. For each Bexagliflozin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bexagliflozin may be tested according to a variety of international standards, such as European Pharmacopoeia (Bexagliflozin EP), Bexagliflozin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bexagliflozin USP).
LOOKING FOR A SUPPLIER?
